Encephalomyelitis News and Research

RSS

Surprise discovery may lead potential treatment for multiple sclerosis

A surprise finding by medical scientists may lead to the development of a possible treatment for multiple sclerosis (MS).

9 Mar 2018

Study reveals how the body clock and time of day may influence autoimmune conditions

Insights into how the body clock and time of day influence immune responses are revealed today in a study published in leading international journal Nature Communications.

12 Dec 2017

Mayo Clinic launches new clinical test that distinguishes IDDs from multiple sclerosis

Mayo Clinic has launched a first-in-the-U.S. clinical test that will help patients who recently have been diagnosed with an inflammatory demyelinating disease (IDD) but may be unsure of the exact disorder.

28 Nov 2017

Researchers uncover how rogue immune cells gain access to neurons in multiple sclerosis

Drug designers working on therapeutics against multiple sclerosis should focus on blocking two distinct ways rogue immune cells attack healthy neurons, according to a new study in the journal Cell Reports.

21 Nov 2017

Discovery may lead to new approach for treating MS

Around 2.5 million people are affected by the autoimmune disease Multiple Sclerosis (MS), the commonest central nervous system disease among young adults.

17 Oct 2017

Study identifies potential biomarker for onset, progression of MS

An article published in Experimental Biology and Medicine identifies Opioid Growth Factor (OGF) as a novel biomarker for the onset and progression of multiple sclerosis (MS).

27 Sep 2017

Columbia University receives $9.6 million NIH grant for ME/CFS research center

The National Institutes of Health has awarded a five-year $9.6 million grant to the Center for Infection and Immunity at Columbia University's Mailman School of Public Health to create the Center for Solutions for Myalgic Encephalomyelitis/ Chronic Fatigue Syndrome (CfS for ME/CFS), an inter-disciplinary, inter-institutional research group dedicated to understanding the biology of the disease in order to develop effective means to diagnose, treat and prevent it.

27 Sep 2017

Novel gene therapy can inhibit, reverse multiple sclerosis in mouse models

Multiple sclerosis can be inhibited or reversed using a novel gene therapy technique that stops the disease's immune response in mouse models, University of Florida Health researchers have found.

21 Sep 2017

Researchers shed new light on MS relapse during upper respiratory infections

For most of us, the flu is just the flu. We suffer through it for several days, and eventually bounce back. But for patients with multiple sclerosis (MS) and other neurological diseases, the flu can trigger a cascade of immune responses that result in a full-blown relapse of the disease.

8 Aug 2017

Experimental treatment tempers HLH, MS symptoms in mouse models, study shows

Immune diseases like multiple sclerosis and hemophagocytic lymphohistiocytosis unleash destructive waves of inflammation on the body, causing death or a lifetime of illness and physical impairment.

23 May 2017

Abnormal levels of specific gut bacteria linked to chronic fatigue syndrome

Scientists at the Center for Infection and Immunity at Columbia University's Mailman School of Public Health have discovered abnormal levels of specific gut bacteria related to chronic fatigue syndrome/myalgic encephalomyelitis, or ME/CFS, in patients with and without concurrent irritable bowel syndrome, or IBS.

26 Apr 2017

Treatment with microRNA re-insulates ravaged nerves, restores limb mobility in mouse models of MS

Scientists partially re-insulated ravaged nerves in mouse models of multiple sclerosis (MS) and restored limb mobility by treating the animals with a small non-coding RNA called a microRNA.

27 Mar 2017

Researchers receive Stafford Fox Medical Research Foundation grant to accelerate CFS diagnosis

Major improvement in the diagnosis of Chronic Fatigue Syndrome is expected following the award of $4m in funding to one of Australia’s foremost authorities on the condition.

2 Dec 2016

Nova Southeastern University hosts international conference organized by IACFS/ME

Chronic fatigue syndrome (CFS), sometimes referred to as myalgic encephalomyelitis (ME), a mysterious, debilitating and misunderstood disease that affects an estimated 1 million Americans, will be the focus of an international conference on October 27-30, 2016.

20 Oct 2016

Encephalomyelitis News and Research

Surprise discovery may lead potential treatment for multiple sclerosis

Study reveals how the body clock and time of day may influence autoimmune conditions

Mayo Clinic launches new clinical test that distinguishes IDDs from multiple sclerosis

Researchers uncover how rogue immune cells gain access to neurons in multiple sclerosis

Discovery may lead to new approach for treating MS

Study identifies potential biomarker for onset, progression of MS

Columbia University receives $9.6 million NIH grant for ME/CFS research center

Novel gene therapy can inhibit, reverse multiple sclerosis in mouse models

Researchers shed new light on MS relapse during upper respiratory infections

Experimental treatment tempers HLH, MS symptoms in mouse models, study shows

Abnormal levels of specific gut bacteria linked to chronic fatigue syndrome

Treatment with microRNA re-insulates ravaged nerves, restores limb mobility in mouse models of MS

Researchers receive Stafford Fox Medical Research Foundation grant to accelerate CFS diagnosis

Nova Southeastern University hosts international conference organized by IACFS/ME

Novel therapeutic strategy could target multiple aspects of Alzheimer's disease

Researchers develop antibody with potential therapeutic effects against multiple sclerosis

Stony Brook researcher receives grant to evaluate daily activity levels, heart rate patterns of CFS patients

Griffith researchers move one step closer to understanding cause of Chronic Fatigue Syndrome

Griffith researchers closer to identifying cause of Chronic Fatigue Syndrome

More neurological resources needed to manage Zika virus infections

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Latest News